Kuo-Chi Cheng
About
Kuo-Chi Cheng is a scholar working on Infectious Diseases, Hepatology and Molecular Biology.
According to data from OpenAlex, Kuo-Chi Cheng has authored 22 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 11 papers in Hepatology and 8 papers in Molecular Biology. Recurrent topics in Kuo-Chi Cheng's work include Hepatitis C virus research (11 papers), HIV/AIDS drug development and treatment (11 papers) and Hepatitis B Virus Studies (5 papers). Kuo-Chi Cheng is often cited by papers focused on Hepatitis C virus research (11 papers), HIV/AIDS drug development and treatment (11 papers) and Hepatitis B Virus Studies (5 papers). Kuo-Chi Cheng collaborates with scholars based in United States and United Kingdom. Kuo-Chi Cheng's co-authors include Perrin C. White, Kenan Qin, F. George Njoroge, Srikanth Venkatraman, Xiao Tong, Latha G. Nair, Stéphane Bogen, Kevin X. Chen, Ashok Arasappan and Frank Bennett and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and Archives of Biochemistry and Biophysics.
In The Last Decade
Kuo-Chi Cheng
22 papers receiving 409 citations
Peers
Kuo-Chi Cheng
Paige E. Mahaney United States
Emiliano Rosatelli Italy
Chayan Acharya United States
Joan D. Ellis United States
Sylvie Klieber France
Paresh K. Patel India
Raquel F. Reinoso Spain
Shirley Cheng United States
Dallas K. Croom United States
Brianne S. Raccor United States
Citations per year, relative to Kuo-Chi Cheng Kuo-Chi Cheng (= 1×)
peers
Paige E. Mahaney
Countries citing papers authored by Kuo-Chi Cheng
Since
Specialization
Citations
This map shows the geographic impact of Kuo-Chi Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kuo-Chi Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kuo-Chi Cheng more than expected).
Fields of papers citing papers by Kuo-Chi Cheng
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Kuo-Chi Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kuo-Chi Cheng. The network helps show where Kuo-Chi Cheng may publish in the future.
Co-authorship network of co-authors of Kuo-Chi Cheng
This figure shows the co-authorship network connecting the top 25 collaborators of Kuo-Chi Cheng. A scholar is included among the top collaborators of Kuo-Chi Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kuo-Chi Cheng. Kuo-Chi Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Nair, Latha G., Stéphane Bogen, Sumei Ruan, et al.. (2010). Towards the second generation of Boceprevir: Dithianes as an alternative P2 substituent for 2,2-dimethyl cycloproyl proline in HCV NS3 protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(5). 1689–1692.
2.
Bennett, Frank, Yuhua Huang, Siska Hendrata, et al.. (2010). The introduction of P4 substituted 1-methylcyclohexyl groups into Boceprevir®: A change in direction in the search for a second generation HCV NS3 protease inhibitor. Bioorganic & Medicinal Chemistry Letters. 20(8). 2617–2621.
3.
Velázquez, Francisco, Mousumi Sannigrahi, Frank Bennett, et al.. (2010). Cyclic Sulfones as Novel P3-Caps for Hepatitis C Virus NS3/4A (HCV NS3/4A) Protease Inhibitors: Synthesis and Evaluation of Inhibitors with Improved Potency and Pharmacokinetic Profiles. Journal of Medicinal Chemistry. 53(8). 3075–3085.
4.
Chen, Kevin X., Bancha Vibulbhan, Weiying Yang, et al.. (2009). Novel potent inhibitors of hepatitis C virus (HCV) NS3 protease with cyclic sulfonyl P3 cappings. Bioorganic & Medicinal Chemistry Letters. 19(4). 1105–1109.
5.
Chang, Lee-Jah, Annette S. Uss, Inhou Chu, et al.. (2009). The impact of protein on Caco-2 permeability of low mass balance compounds for absorption projection and efflux substrate identification. Journal of Pharmaceutical and Biomedical Analysis. 51(5). 1069–1077.
6.
Venkatraman, Srikanth, Wanli Wu, Latha G. Nair, et al.. (2009). Discovery of novel P3 sulfonamide-capped inhibitors of HCV NS3 protease. Inhibitors with improved cellular potencies. Bioorganic & Medicinal Chemistry. 17(13). 4486–4495.
7.
Arasappan, Ashok, Edwin Jao, Frank Bennett, et al.. (2009). Toward Second Generation Hepatitis C Virus NS3 Serine Protease Inhibitors: Discovery of Novel P4 Modified Analogues with Improved Potency and Pharmacokinetic Profile. Journal of Medicinal Chemistry. 52(9). 2806–2817.
8.
Ho, Ginny D., John C. Anthes, John P. Caldwell, et al.. (2009). The discovery of tropane derivatives as nociceptin receptor ligands for the management of cough and anxiety. Bioorganic & Medicinal Chemistry Letters. 19(9). 2519–2523.
9.
Bogen, Stéphane, Weidong Pan, Sumei Ruan, et al.. (2009). Toward the Back-Up of Boceprevir (SCH 503034): Discovery of New Extended P4-Capped Ketoamide Inhibitors of Hepatitis C Virus NS3 Serine Protease with Improved Potency and Pharmacokinetic Profiles. Journal of Medicinal Chemistry. 52(12). 3679–3688.
10.
Wang, Ganfeng, Yunsheng Hsieh, Kuo-Chi Cheng, et al.. (2007). Ultra-performance liquid chromatography/tandem mass spectrometric determination of diastereomers of SCH 503034 in monkey plasma. Journal of Chromatography B. 852(1-2). 92–100.
11.
Li, Guo‐Qing, Andrew W. Stamford, Ying Huang, et al.. (2007). Discovery of novel orally active ureido NPY Y5 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 18(3). 1146–1150.
12.
Chen, Kevin X., Bancha Vibulbhan, Weiying Yang, et al.. (2007). Potent and selective small molecule NS3 serine protease inhibitors of Hepatitis C virus with dichlorocyclopropylproline as P2 residue. Bioorganic & Medicinal Chemistry. 16(4). 1874–1883.
13.
Chen, Kevin X., F. George Njoroge, Ashok Arasappan, et al.. (2006). Novel Potent Hepatitis C Virus NS3 Serine Protease Inhibitors Derived from Proline-Based Macrocycles. Journal of Medicinal Chemistry. 49(3). 995–1005.
14.
Cheng, Kuo-Chi. (1992). Molecular cloning of rat liver 3α-hydroxysteroid dehydrogenase and identification of structurally related proteins from rat lung and kidney. The Journal of Steroid Biochemistry and Molecular Biology. 43(8). 1083–1088.
15.
Cheng, Kuo-Chi, Perrin C. White, & Kenan Qin. (1991). Molecular Cloning and Expression of Rat Liver 3α-Hydroxysteroid Dehydrogenase. Molecular Endocrinology. 5(6). 823–828.
16.
Cheng, Kuo-Chi. (1991). Detection of multiple antigenically related proteins from various rat tissues by monoclonal antibodies against 3α-hydroxysteroid dehydrogenase. Archives of Biochemistry and Biophysics. 291(2). 258–262.
17.
Cheng, Kuo-Chi, et al.. (1988). Peptide-specific antibodies employed in determining the interspecies immunological cross-reactivity of haemopexin. Comparative Biochemistry and Physiology Part B Comparative Biochemistry. 91(3). 467–472.
18.
Robinson, Richard C., et al.. (1986). Structural comparison of monoclonal antibody immunopurified pulmonary and hepatic cytochrome P-450 from 3-methylcholanthrene-treated rats. Biochemical Pharmacology. 35(21). 3827–3830.
19.
Cheng, Kuo-Chi, Henry C. Krutzsch, Sang S. Park, et al.. (1984). Amino-terminal sequence analysis of six cytochrome P-450 isozymes purified by monoclonal antibody directed immunopurification. Biochemical and Biophysical Research Communications. 123(3). 1201–1208.
20.
Schenkman, John B., Ingela Jansson, Wayne L. Backes, Kuo-Chi Cheng, & Carolyn J. Smith. (1982). Dissection of cytochrome P-450 isozymes (RLM) from fractions of untreated rat liver microsomal proteins. Biochemical and Biophysical Research Communications. 107(4). 1517–1523.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Paige E. Mahaney Breakdown of academic impact, for papers by Emiliano Rosatelli Breakdown of academic impact, for papers by Chayan Acharya Breakdown of academic impact, for papers by Joan D. Ellis Breakdown of academic impact, for papers by Sylvie Klieber Breakdown of academic impact, for papers by Paresh K. Patel Breakdown of academic impact, for papers by Raquel F. Reinoso Breakdown of academic impact, for papers by Shirley Cheng Breakdown of academic impact, for papers by Dallas K. Croom Breakdown of academic impact, for papers by Brianne S. Raccor